NCT06364306 oPen Versus RobotIc retrOmuscular Repair in Medium to Large Ventral Hernias
| NCT ID | NCT06364306 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Ventral Hernia |
| Study Type | INTERVENTIONAL |
| Enrollment | 140 participants |
| Start Date | 2026-07-14 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 140 participants in total. It began in 2026-07-14 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates on the effect of two different operative techniques to treat large abdominal wall defects. The goal of this clinical trial is to learn if the minimally-invasive, robotically-assisted ventral hernia repair (RVHR) leads to a better outcome than the open ventral hernia repair (OVHR). The main questions it aims to answer are: length of stay after the operation rate of complications rate of recurrence and reoperations quality of life. Participants will: Either be operated using the RVHR or OVHR will be followed up either in person or via email / phone call at day 7, day 30, 6 months, 1, 3 and 5 years after the surgery to asses the above-stated main and some more outcomes.
Eligibility Criteria
Inclusion Criteria: * Patient age \>18 years * Informed consent obtained * Transverse diameter of ventral hernia \>4cm - 15cm * Eligible to open and minimally-invasive surgery according to preoperative anaesthetic assessment Exclusion Criteria: * precedent hernia treatment with mesh placement in the retromuscular space * precedent anterior or posterior component separation or transversus abdominis release (TAR) * active wound infection * current cancer diagnosis * presence of ileostomy, colostomy or ileal conduit * liver disease defined by the presence of ascites * end-stage renal disease requiring dialysis * need of an emergency surgery * pregnancy Criteria for participating surgeons Each participating surgeon has performed 20 or more OVHR and RVHR.
Contact & Investigator
Johannes Baur, MD
PRINCIPAL INVESTIGATOR
Clarunis - Universitäres Bauchzentrum Basel
Frequently Asked Questions
Who can join the NCT06364306 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Ventral Hernia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06364306 currently recruiting?
Yes, NCT06364306 is actively recruiting participants. Contact the research team at fiorenzo.angehrn@clarunis.ch for enrollment information.
Where is the NCT06364306 trial being conducted?
This trial is being conducted at Kempten (Allgäu), Germany, Basel, Switzerland, Visp, Switzerland.
Who is sponsoring the NCT06364306 clinical trial?
NCT06364306 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Johannes Baur, MD at Clarunis - Universitäres Bauchzentrum Basel. The trial plans to enroll 140 participants.